About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

3 Hous. J. Health L. & Pol'y 1 (2002-2003)
Human Tissues and Reproductive Cloning: New Technologies Challenge FDA

handle is hein.journals/hhpol3 and id is 7 raw text is: 3 Hous. J. HEALTH L. & POL'Y 1-82                                         1
Copyright © 2002 Richard A. Merrill,
Houston Journal of Health Law & Policy
ISSN 1534-7907
HUMAN TISSUES AND
REPRODUCTIVE CLONING:
NEW TECHNOLOGIES CHALLENGE FDA
Richard A. Merrill*
INTRODUCTION
It is conventional wisdom that regulatory agencies possess dis-
cretion to interpret their program statutes in new ways in order to
meet challenges that the congressional authors did not, and in many
cases could not, anticipate. The Supreme Court's famous Chevron
decision promises, even if it does not guarantee, that reviewing
courts will defer to an agency's modernizing initiatives unless it can
be shown that Congress specifically foreclosed them.' Thus we
have come to expect that agencies will often confront new chal-
lenges by adapting traditional tools, rather than reflexively re-
turning to the legislature for new authority or instructions. Indeed,
agencies often prefer to work within the framework of their original
charters, both so as to appear responsive and to avoid the real risk
that new legislation will repudiate or undo policies to which they
have long been committed.
There must, of course, be limits to administrative interpolation,
though it may be futile to attempt to describe them in general terms.
Chevron's dictate, that when Congress has spoken clearly to the pre-
*Daniel Caplin Professor of Law, University of Virginia, A.B., Columbia, 1959; M.A., Ox-
ford, 1961; LL.B., Columbia, 1964. Mr. Merrill served as Chief Counsel to the U.S. Food
and Drug Administration from 1975 to 1977. Since 1991 he has been Senior Of Counsel to
the law firm of Covington & Burling, where he specializes in food and drug law and
advises many clients engaged in biomedical research and the development and marketing
of medical products, including the American Association of Tissue Banks. The views ex-
pressed in this article are entirely his own. I want in particular to express appreciation to
Bryan Rose of the University of Virginia Law School Class of 1999, who educated me
about the science underlying and the debate surrounding cloning. Thanks also for re-
search assistance provided by Michael Brunet of the University of Virginia Law School
Class of 2004.
1 Chevron, U.S.A., Inc. v. Natural Resources Defense Council, Inc., 467 U.S. 837, 844 (1984).

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most